New Drug Approvals Archive
Cubicin (daptomycin )
New Dosage Regimen: November 30, 2010
New Dosage Regimen: December 13, 2010
Safyral (drospirenone, ethinyl estradiol and levomefolate calcium) Tablets
Date of Approval: December 16, 2010
Safyral (drospirenone, ethinyl estradiol and levomefolate calcium) is an estrogen/progestin combined oral contraceptive containing a folate, indicated for use by women to prevent pregnancy, and to raise folate levels in women who choose to use an oral contraceptive for contraception.
Gardasil (human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant)
New Indication Approved: December 22, 2010
Amturnide (aliskiren, amlodipine and hydrochlorothiazide) Tablets
Date of Approval: December 21, 2010
Amturnide (aliskiren, amlodipine and hydrochlorothiazide) is a direct renin inhibitor, calcium channel blocker and diuretic combination for the treatment of high blood pressure.
Fortesta (testosterone) Gel
Date of Approval: December 29, 2010
Fortesta (testosterone) Gel is a topical androgen indicated for replacement therapy in male hypogonadism.